Tonix Pharmaceuticals
TNXP
1 hedge funds and large institutions have $683K invested in Tonix Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
62% more capital invested
Capital invested by funds: $421K → $683K (+$262K)
0% more funds holding
Funds holding: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$663K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$663K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$46K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $272K | +$663K | +1 | New |
|
|
2
Renaissance Technologies
New York
| $217K | -$663K | -1 | Closed |
|
3
Citadel Advisors
Miami,
Florida
| $60K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $59K | – | – | – |
|
5
Northern Trust
Chicago,
Illinois
| $19K | – | – | – |
|
6
HighTower Advisors
Chicago,
Illinois
| $15K | – | – | – |
|
7
Victory Capital Management
San Antonio,
Texas
| $12K | – | – | – |
|
|
SFS
8
Sowell Financial Services
North Little Rock,
Arkansas
| $11K | – | – | – |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $7K | – | – | – |
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $7K | – | – | – |
|
|
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $3.55K | – | – | – |
|
|
12
Acadian Asset Management
Boston,
Massachusetts
| – | -$46K | – | – |
|
TNXP Hedge Fund Activity: Q1 2020 in Review
1 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q1 2020, worth a combined $683K — up 62% from $421K a quarter earlier.
Fund positioning in TNXP was balanced in Q1 2020: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $663K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $663K sold.
- 1 institutional investor held Tonix Pharmaceuticals (TNXP) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $683K of Tonix Pharmaceuticals stock for Q1 2020, up 62% quarter-over-quarter.
- 1 fund opened new Tonix Pharmaceuticals positions in Q1 2020 and 1 closed out, a net change of 0 holders.
- The largest Tonix Pharmaceuticals buyer in Q1 2020 was Vanguard Group, an estimated $663K added.
- The largest Tonix Pharmaceuticals seller in Q1 2020 was Renaissance Technologies, an estimated $663K sold.
Based on aggregated 13F filings for Q1 2020.